Organization
Otovia Therapeutics
1 clinical trial
Clinical trial
An Investigator Initiated Study Evaluating the Safety, Tolerability, and Efficacy of OTOV101N+OTOV101C Injection in Treating Patients With OTOF Mutation-related DeafnessStatus: Recruiting, Estimated PCD: 2024-12-06